PREGABALIN in Danish translation

• pregabalin

Examples of using Pregabalin in English and their translations into Danish

Steady-state trough plasma concentrations of lamotrigine were not affected by concomitant pregabalin(200 mg, 3 times daily) administration.
De laveste plasmakoncentrationer af lamotrigin ved steady state blev ikke påvirket af samtidig administration af pregabalin 200 mg tre gange dagligt.

For patients receiving haemodialysis, the pregabalin daily dose should be adjusted based on renal function.
Hos patienter, der er i hæmodialysebehandling, skal den daglige dosis af pregabalin justeres i forhold til nyrefunktionen.

In preclinical studies, there was no indication of racemisation of pregabalin S- enantiomer to the R-enantiomer.
I prækliniske studier ses ingen tegn på racemisering af pregabalins S- enantiomer til R- enantiomer.

impaired liver function would not be expected to significantly alter pregabalin plasma concentrations.
anses det ikke for sandsynligt, at nedsat leverfunktion signifikant vil ændre pregabalins plasmakoncentrationer.

In controlled clinical trials(4-8 week duration) 52% of the pregabalin treated patients and 38% of the patients on placebo had at least a 50% improvement in HAM-A total score from baseline to endpoint.
I de kontrollerede kliniske studier(af 4- 8 ugers varighed) opnåede 52% af patienterne behandlet med pregabalin og 38% af patienterne på placebo mindst en 50% forbedring i HAM- A totalscore fra baseline til endpoint.

The N- methylated derivative of pregabalin, the major metabolite of pregabalin found in urine, accounted for.
Det N- methylerede derivat af pregabalin, der er pregabalins hovedmetabolit, genfindes i urin og svarer til 0.

Pregabalin appears to be additive in the impairment of cognitive
Pregabalin synes at være additiv ved den nedsættelse af kognitiv

Pregabalin induced offspring developmental toxicity in rats at exposures> 2 times the maximum recommended human exposure.
I præ- natale/ post- natale toksicitetsundersøgelser fremkalder pregabalin udviklingstoksicitet hos afkom af rotter ved doser> 2 gange den maksimale anbefalede humane dosis.

After stopping long and short-term pregabalin treatment, you need to know that you may experience certain side effects.
Når De stopper med at tage pregabalin efter langtidsbehandling eller korttidsbehandling, har De brug for at vide, at De måske oplever visse bivirkninger.

Pregabalin is not genotoxic based on results of a battery of in vitro and in vivo tests.
Pregabalin er ikke genotoksisk på baggrund af in- vitro og in vivo tests.

The N- methylated derivative of pregabalin, the major metabolite of pregabalin found in urine,
Det N- methylerede derivat af pregabalin, der er pregabalins hovedmetabolit, genfindes i urin

Clinical trials indicate that gender does not have a clinically significant influence on the plasma concentrations of pregabalin.
Kliniske forsøg tyder på, at køn ikke har nogen klinisk betydende indflydelse på plasmakoncentrationen af pregabalin.

The active substance, pregabalin, is a gamma-aminobutyric acid analogue(S)-3-(aminomethyl)-5- methylhexanoic acid.
Det aktive indholdsstof, pregabalin, er en gamma- aminosmørsyre analog(S)- 3-(aminomethyl)- 5- methylhexansyre.

Pregabalin has been shown to cross the placenta in rats
Pregabalin har vist sig at krydse placenta hos rotter

Do not take LYRICA if you are allergic(hypersensitive) to pregabalin or any of the other ingredients of Lyrica.
Hvis De er overfølsom(allergisk) over for pregabalin, eller et af de øvrige indholdsstoffer.

coma in patients taking pregabalin and other CNS depressant medications.
rapporteret om respirationssvigt og koma hos patienter, der tager pregabalin og andre CNS- depressiva.

severity of withdrawal symptoms in relation to duration of use and dosage of pregabalin.
relation til varighed og dosering af pregabalin i forbindelse med seponering af langtidsbehandling med pregabalin.

Pregabalin binds to an auxiliary subunit(α2-δ protein)
Pregabalin bindes til en hjælpeundergruppe(α2- δ protein)

such an improvement was observed in 33% of patients treated with pregabalin and 1 8% of patients on placebo.
ses en sådan forbedring hos 33% af patienterne behandlet med pregabalin og hos 18% af patienterne behandlet med placebo.

In all controlled studies, the discontinuation rate due to adverse reactions was 13% for patients receiving pregabalin and 7% for patients receiving placebo.
I de kontrollerede forsøg udgik 13% af patienterne, der fik pregabalin, og 7% af patienterne, der fik placebo, på grund af bivirkninger.